|
Volumn 36, Issue 2, 2001, Pages 169-175
|
Cost avoidance and clinical benefits derived from a pharmacy-managed anemia program
a a a a a |
Author keywords
Anemia; Cost avoidance; Erythropoeitin
|
Indexed keywords
IRON;
NEPHRON FA;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG UTILIZATION;
HEALTH CARE COST;
HEMATOCRIT;
HEMODIALYSIS PATIENT;
HUMAN;
PHARMACIST;
PHARMACY;
REVIEW;
|
EID: 0035109387
PISSN: 00185787
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (9)
|